Comparative effectiveness of dual antiplatelet therapy after revascularization in diabetes and chronic limb-threatening ischemia: a target trial emulation study.
It is suggested that aspirin plus cilostazol may be a favorable DAPT strategy for long-term outcomes in this population of patients with diabetes and CLTI undergoing lower-extremity revascularization, and further prospective randomized trials are warranted to verify.